Cite
HARVARD Citation
Varettoni, M. et al. (2019). A risk‐stratification model based on the initial concentration of the serum monoclonal protein and MYD88 mutation status identifies a subset of patients with IgM monoclonal gammopathy of undetermined significance at high risk of progression to Waldenström macroglobulinaemia or other lymphoproliferative disorders. British journal of haematology. pp. 441-446. [Online].